Generics

Innovative 1

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-021 manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Canada

Clear all

1 products found

pp-021

Softgel capsules 100 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Canada
Comments
Indication: Dry AMD, prevention of dry-to-wet AMD conversion, wet AMD; Ph II; oral formulation, once-daily small-molecule systemic modulator with intraocular activity (anti-inflammatory/anti-oxidative/anti-angiogenic effect); crosses the blood-retina barrier; complementary to intravitreal therapies. VAP info: There is no approved oral therapy for AMD today; current standards are intravitreal injections.
Manufacturer #38499

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.